Hims & Hers (HIMS) Stock Falls More Than Broader Market: What's Happening?

HIMS stock closed at $59.15, a -5.75% change from the previous day, while the S&P 500 only lost 0.63%. Why does this matter? This underperformance signals specific challenges or investor concerns related to HIMS.

Despite the recent drop, HIMS shares had gained 24.65% in the past month, outperforming both the Medical sector and the S&P 500. This highlights the stock's volatility and the importance of considering longer-term trends.

The company is set to release its earnings report on November 3, 2025, with forecasts indicating an EPS of $0.09 (50% increase year-over-year) and revenue of $581.61 million (44.84% increase year-over-year). Investors are closely watching these figures as indicators of future performance.

Full-year forecasts predict earnings of $0.6 per share and revenue of $2.35 billion, representing significant growth compared to the previous year (+122.22% and +59.03%, respectively). These projections suggest strong potential if the company meets expectations.

Forward P/E Ratio:: HIMS has a Forward P/E ratio of 105.22, significantly higher than the industry average of 40.64. This indicates that the stock is trading at a premium compared to its peers.

PEG Ratio:: The company's PEG ratio is 4.29, also higher than the Medical Info Systems industry average of 3.33. A higher PEG ratio might suggest that the stock is overvalued relative to its expected earnings growth.

Q: Why did HIMS stock fall more than the market?

Q: When is the next earnings report?

Monitor HIMS's upcoming earnings report on November 3, 2025, to see if it meets growth expectations.

Pay attention to analyst estimates and any revisions, as these can significantly impact stock performance.

Consider the company's valuation metrics, such as its Forward P/E and PEG ratios, in relation to its industry peers.